Syndax Medical Affairs / Information
Ask a Question
Clinical Trials
Disease Information
Find your MSL
Footer
Header
Publications
Resources
Syndax Medical Affairs
Presentation Type:
Oral Presentation
Revumenib as maintenance for AML following allogeneic stem cell transplantation.
May 27, 2026